Philippe Verwaerde

AlzProtect SAS operates as a biotechnological company. It develops therapeutical solutions for neurodegenerative diseases. The company was founded by Andre Delacourt and Patricia Melnyk in November 2007 and is headquartered in Loos, France.

deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium.

Part of GSK Plc, Glaxo Wellcome SA is a Spanish company that manufactures and markets medicines. The company is based in Aranda de Duero, Spain.

Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million.

Vivactis SAS specializes in healthcare communications and marketing services. The company is based in Neuilly-sur-Seine, France. The French company was founded by Jean-Claude Sauli, Philippe Verwaerde. Vivactis was acquired by Vivactis Group SA on February 29, 2008.